6-Methylnicotinamide CAS 6960-22-1 Purity >98.0% (HPLC)

Short Description:

Chemical Name: 6-Methylnicotinamide 

CAS: 6960-22-1

Purity: >98.0% (HPLC) (T) 

Appearance: White to Light Yellow Powder to Crystal

High Quality, Commercial Production

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-Methylnicotinamide (CAS: 6960-22-1) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name 6-Methylnicotinamide 
Synonyms 2-Methylpyridine-5-Carboxamide; 6-Methylpyridine-3-Carboxamide; 6-Methyl-3-Pyridinecarboxamide; 6-Methylnicotinic Acid Amide
CAS Number 6960-22-1 
CAT Number RF2540
Stock Status In Stock, Production Capacity 30 Tons per Month 
Molecular Formula C7H8N2O 
Molecular Weight 136.15   
Melting Point 197.0 to 201.0℃
Density 1.157±0.06 g/cm3
Solubility in Water Soluble in Water
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White to Light Yellow Powder to Crystal
Purity / Analysis Method >98.0% (HPLC) 
Purity / Analysis Method >98.0% (Nonaqueous Titration) 
Melting Point 197.0~201.0℃
Loss on Drying <1.00%
Residue on Ignition <0.50%
Total Impurities <2.00%
Infrared Spectrum Conforms to Structure
Proton NMR Spectrum Conforms to Structure
Solubility in Water Soluble 50 mg/mL, Clear to Slightly Hazy, Colorless to Light Yellow
Test Standard Enterprise Standard

Package & Storage:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

FAQ:

How to Purchase? Please contact: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Russia, Korea, Japanese, Australia, etc.

Advantages? Excellent quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

Application:

6-Methylnicotinamide (CAS: 6960-22-1) can be used in chemical synthesis studies, is an important raw material and intermediate used in organic synthesis, pharmaceuticals. 6-Methylnicotinamide is a nicotinamide derivative that inhibits state 3 respiration in isolated rat liver mitochondria. It is toxic to rat B65 neuroblastoma cells and is used in studies associated with early symptoms of Parkinson's disease.

  • Write your message here and send it to us